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Abstract
Background: Maternal exposures to organochlorines prior to pregnancy are considered a risk to
neonatal welfare, specifically in relation to neurocognitive functions. There is growing interest in
the evaluation of maternal blood testing as a marker for fetal exposure as well as the variable
geographic distribution of these priority chemicals.
Methods: Three hundred and twenty-three women in the second trimester of pregnancy entered
the study at a prenatal clinic providing genetic counselling information. Subjects who had an
indication for genetic amniocentesis based on late maternal age were eligible to participate. Two
hundred and thirty-eight completed an environmental questionnaire. A sample of amniotic fluid was
taken for karyotype analysis in 323 women and blood samples during pregnancy (209), at birth
(105) and from the umbilical cord (97) and breast milk (47) were also collected. These samples
were tested for 29 PCB congeners and organochlorine pesticides.
Results: The concentrations of PCB 153 in these media were relatively low in relation to other
studies. Σ PCBs measurements in samples taken during the second trimester of pregnancy, at birth
and in the umbilical cord were strongly correlated. Specific measurements of PCB 153 and PCB
180 among those subjects with completed sampling of blood samples from mothers and cord
samples were significantly correlated. The concentrations of PCBs and pesticides did not differ in
relation to prior spontaneous abortion history. There were no organochlorines present in the
amniotic fluid at the current level of quantification.
Conclusion: Pregnant women from the Western Canada region of Calgary, Alberta are exposed
to relatively low concentrations of organochlorines. Measurement of maternal blood during the
second trimester of pregnancy can reliably estimate the fetal exposure to PCBs. This estimate is
reliable for Group 2 and 3 PCBs as well as PCB 153 and PCB 180. The amniotic fluid does not
contain measurable concentrations of pesticides and PCBs under the conditions of the levels of
quantification.
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Background
Polychlorinated biphenyls (PCBs) are ubiquitously
present in the ecosystem and have been reported in the tis-
sues of many animals and human population groups [1].
They are persistent and biomagnify in biota such that
humans and predators at the top of the food chain experi-
ence the highest concentrations. Banned production of
organochlorines in Canada and the United States in the
1970's has had an important effect in reducing exposure
to these chemicals but because of the large residual quan-
tities, release from storage and the limited rates of envi-
ronmental degradation, they are still considered present
in the environment. There is increasing interest in the geo-
graphic distributions of these chemicals and their poten-
tial impact on human health[2,3]
Maternal exposure to PCBs and organochlorine pesticides
is an area of intense research. This is due to the potential
long term effects of organochlorine exposure in the fetus
and newborn[4]. Potentially severe adverse health effects
during pregnancy have included preterm labor and intra-
uterine growth restriction in association with DDE, but
the effects occurred at levels identified during the period
1959–1966[5]. These concentrations are substantially
above exposure levels generally observed among current
populations [6].
Postnatal adverse events have focused on the known neu-
rotoxic effects of polychlorinated biphenyls [7]. Several
studies have implicated exposure to these chemicals with
impaired intellectual function in children [8-10]. Impor-
tantly the findings have demonstrated modest but signifi-
cant effect sizes [10]. The potential mechanisms
underlying these findings is unknown but recently dose-
response relationships have been found between the con-
centrations of PCBs among members of the Oswego study
and increases in response inhibition errors as well as
reduced size of the splenium of the corpus callosum [11].
Another proposed mechanism of toxicity in the develop-
ing brain is the potential for altered thyroid function, a
known contributor to impaired intelligence among new-
borns [12-14]. There is now evidence the actions of PCBs
may reflect a direct effect of the chemical on the action of
thyroid hormone in the absence of altered hormone con-
centrations [15]
The severity of the potential adverse central nervous sys-
tem effects in children and the possibility that early intra-
uterine exposure to organochlorines is a determinant of
impaired intelligence indicates a need for further exposure
information. There is little information related to the lon-
gitudinal patterns of PCB levels in women during the
pregnancy. In some cases there was no correlation
between maternal and cord samples [16], although others
have reported that there is a strong correlation [17]. The
measurement of serum concentrations over the course of
the pregnancy and delivery appears not to have been
explored in detail previously although the ability to eval-
uate fetal exposure during pregnancy is an important
objective, particularly because of the susceptibility of the
developing nervous system.
This study was undertaken to define the concentrations of
PCBs and organochlorine pesticides in amniotic fluid,
maternal blood collected during the second trimester, and
at the time of birth, cord blood and breast milk among a
cohort of pregnant women from Calgary, Alberta, Can-
ada. The inter-relationships of the concentrations in these
compartments were of interest to determine if maternal
blood levels measured during pregnancy could serve as a
proxy for fetal exposure. Further, we were particularly
interested in the concentrations of PCBs in the Calgary
region compared to other studies that had evaluated neu-
rocognitive development in local children. Finally, there
was an interest in evaluating the concentrations of PCB
153 in light of its proposed use for comparing across envi-
ronmental epidemiologic studies of PCB toxicity [18].
Methods
Pregnant women attending a prenatal counselling session
at Foothills Hospital in the Calgary Health Region, Cal-
gary, Alberta were approached to participate in this
project. Approval of the project was obtained from the
University of Calgary Ethics Committee. Three hundred
and twenty-three subjects were enrolled after their eligibil-
ity to participate was determined. They were required to
be seeking genetic counselling for the purpose of age-
related indications and not to have another reason for
such counselling. Subjects were also required to be 35
years of age at the time of entry
Of those agreeing to participate, two hundred and thirty-
eight completed an environmental questionnaire. A sam-
ple of amniotic fluid was available from three hundred
and twenty-three women. A blood sample at the same
time as the amniocentesis during the second trimester of
pregnancy was available from 209 women. A blood sam-
ple at the time of delivery was made available in 105
women. Cord blood samples were collected from 97
women and a sample of breast milk was collected from 47
women after birth and during the puerperium from
home. Clinical information related to the pregnancy and
delivery was collected at the three Calgary hospitals and
three hospitals outside the Calgary health region. All sub-
jects were given the special tubes and phlebotomy sup-
plies to submit various blood and breast milk samples
and contacted on a regular basis for the completion of the
sampling. The nursing staff on each delivery suite was ori-
ented to the project to gain maximal compliance with the
study.Environmental Health: A Global Access Science Source 2005, 4:10 http://www.ehjournal.net/content/4/1/10
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The blood samples were collected by the regional labora-
tory in specially prepared glass tubes, centrifuged and the
serum transferred to the Centre for Toxicology, University
of Calgary for analysis. A similar approach was used for
amniotic fluid. It should be noted that subjects were not
required to fast for the blood samples, either during preg-
nancy or at birth.
The samples were assayed at the Centre for Toxicology,
University of Calgary. They underwent sample clean-up
and extraction by solid phase extraction techniques.
Details of the methods have been previously reported
[19,20]The PCBs and most pesticides were measured with
GC/negative chemical ionization spectrometry (GC/
NCIMS). Some pesticides were measured with GC/elec-
tron ionization mass spectrometry (GC/EIMS). The Cen-
tre participated in the Intercomparison Program for
Toxicological Analysis in Biological Materials, University
of Erlangen-Nuremberg, and the performance had been
good
In amniotic fluid the PCBs measured were as follows:
PCB- 70, 74, 77, 87, 99, 101, 105, 118, 128, 138, 151,
153, 156, 169, 170, 180, 183, 187, 191, 194, 205, 206,
208, 209. The pesticides measured were: Aldrin, p, p'-
DDE, p, p'-DDT, dieldrin, endosulfan I and II, endrin,
heptachlor, hexachlorobenzene, hexachlorocyclohexanes,
α-,β-,γ-, hexachloroethane, methoxychlor, mirex, pen-
tachlorobenzene, 1,2,3-trichlorobenzene, 1,2,4-trichlo-
robenzene, 1,2,3,4-tetrahlorobenzene. These analytes
were also measured in serum and breast milk with some
minor changes
The limit of quantification (LOQ) varied among analytes
as well as matrices. For example, the LOQ for most PCBs
was 0.01 ng/ml in all matrices. The LOQ for most other
industrial chemicals was 0.05 ng/ml, however there were
exceptional situations. For example, the LOQ for p, p'-
DDT was 0.5 ng/ml. In order to evaluate the measure-
ments of Σ PCBs and Group 2 and 3 PCBs, 1/2 of the level
of detection was used in analysis. This may result is some
bias in the analysis as only PCB 153, 138, 180 and 170
had detection rates >90% in maternal blood during preg-
nancy. There were similar patterns of detection rates for
the PCBs 153, 138 and 103 in maternal blood at birth and
PCBs 153 in cord blood and PCB 118, 153, 138, 187, 183,
156, 180, 170 and 194 in breast milk. The presence of bias
in the use of this technique is appreciated. Other
approaches such as the use of designation of non-detected
samples as zero values was not used because the values are
called non-ignorable data that may also result bias if the
samples are simply excluded. Alternative imputation anal-
ysis approaches may provide more accurate methods for
pregnancy related PCBs but will need to be confirmed in
comparison to other studies [21].
The lipid content of serum was calculated by the sum of
cholesterol, triglycerides and phospholipids. These ana-
lytes were measured by enzymatic methods using a chem-
istry analyzer. The lipid content of milk was measured by
a gravimetric method.
Statistical analysis
The data from the clinical charts, analysis of chemical
results and the environmental questionnaires were assem-
bled in SPSS. Only normally distributed data were evalu-
ated using parametric analysis (paired t-test and Pearson
Correlation). Parametric analysis was undertaken wher-
ever possible. The individual analytes were not normally
distributed and were normalized by logarithmic function
and adjusted to account for non-detection of samples. All
PCB concentrations were highly skewed. Samples were
corrected for non-detection (0.5*level of quantification),
lipid adjusted and log transformed for a normal distribu-
tion. Because the relationships of maternal blood to cord
blood are key in this study and the fetal blood is lower in
lipid content, PCBs levels were evaluated as ng/ml and as
ng/g lipid. Specific analysis was done on PCB 153 because
of the relatively high concentrations observed. Samples
also were aggregated by measuring Σ PCBs as well as Σ
PCBs in Group 2 and Group 3 of those proposed by Wolff
et al. [22]. For this study, Group 2 included PCBs 74, 118,
156, 138 and 170. Group 3 included PCBs 99, 153, 180
and 183. Data concerning the concentrations of HCB and
DDE were treated in a similar fashion for non-detection
and normalization.
To explore changes in the concentrations in pregnancy,
paired t-tests were undertaken between all possible group-
ings of samples on the normalized data. Although there
were sufficient pairings to evaluate differences in the pair
groups, it is important to note these comparisons do not
exactly reflect the same cohort over the four periods of
study because of missing data. In order to evaluate the cor-
relation of the results, and bearing in mind the desire to
study the maternal blood during pregnancy and at birth as
a potential marker of fetal exposure, the non-lipid
adjusted samples were normalized for comparison pur-
poses. The non-detection samples were adjusted to reflect
0.5 the level of quantification.
To evaluate the potential association of exposures to
spontaneous abortion, the concentrations were assessed
in relation to clinical history by one way analysis of
variance.
Results
Demographics
The subjects were all from the Calgary Health Region,
located in southern Alberta, Canada during the period
from an entry in 2001 to 2003 when the last deliveryEnvironmental Health: A Global Access Science Source 2005, 4:10 http://www.ehjournal.net/content/4/1/10
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occurred. A total of 323 subjects were approached and
315 subjects completed the consent form and formally
entered into the study. From this group, 308 provided
samples of amniotic fluid for karyotype studies as well as
the measurement of the organochlorines. The balance of
subjects decided not to have the amniocentesis under-
taken based upon information from the Genetics Coun-
selling Clinic. There were 209 blood samples collected
during the second trimester around the time of the amni-
ocentesis. There were 105 blood samples analyzed from
the mothers at the time of giving birth. There were 97 sam-
ples of cord blood and 47 samples of breast milk col-
lected. The breast milk samples were collected at varying
times in the postpartum period.
There were 203 pairs of amniotic fluid and maternal
blood during the time of amniocentesis and 85 pairs of
samples that were obtained from maternal blood at birth
and cord samples. There were 23 subjects in which all
samples were collected in all tissues compartments.
The demographic and reproductive histories of the sub-
jects are presented in Table 1. Consistent with the inclu-
sion criteria, the age of the subjects was 39.0+/- 0.1
(Mean+/- SEM). During the previous year, 15.1% of the
subjects identified themselves as smokers and 8% contin-
ued to smoke during the pregnancy. Most of these smok-
ers reported smoking less than 20 cigarettes per day (see
Additional file: 1).
A specific diet was reported by 66 subjects including
weight loss (13.4%), sodium free (3.4%), fat free (8.4%),
diabetic (0.4%), weight gain (0.4%) and vegetarian
(1.7%). Eighty five individuals reported a significant
weight loss on the preceding year and the average amount
was reported to be 7.3 pounds.
Prior medical history was significant for the regular use of
prescription medication (27%), Anesthetic exposure
(18%), and infertility (12%). There was an infrequent rate
of prior cancer (2.1%), skin disease (2.9 %) and liver dis-
ease (1.7%).
The most common chemical exposure in the previous year
was to paint (50.5%) and solvents (32.8%). There was a
reported exposure of this cohort to pesticides in 22%, her-
bicides 22%, fungicides 5.9% and dry cleaning chemicals
6.5%.
Of the cohort, there were only 36 primigravidas. Sixteen
percent reported one induced abortion and 6% had had 2
or more. There were 21% of the subjects with one, 6.3%
with two and 6% with three or more spontaneous abor-
tions. Two percent reported an ectopic pregnancy.
Of the pregnancies under review, there were 291 births, of
which there was a complication rate of pregnancy of preg-
nancy induced hypertension in 8.2%, premature labor in
3.4%, gestational diabetes in 5.2% a birth weight less than
2500 g in 4.8% and a Caesarean section rate of 27%.
The sex ratio of the cohort of infants was 1.13 (male/
female). Karyotype indicated two cases of Klinefelter syn-
drome and 2 cases of trisomy that proceeded to delivery.
Other anomalies resulted in pregnancy termination.
Concentrations of the Organochlorine Chemicals
Amniotic Fluid
None of the PCBs or pesticides was measurable in the
amniotic fluid. It should be noted the amniotic fluid
measurement was done after centrifugation and the amni-
ocytes removed for karyotyping.
Total PCBs and Pesticides
The concentrations of all available samples of PCB 153, Σ
PCBs, Group 2 and Group 3 PCBs and the pesticides DDE
and HCB (lipid adjusted) are presented in Additional file:
2. Statistical analysis was performed for Σ PCB samples
using a paired t-test of normalized data. In relation to
ΣPCBs, samples collected from women during pregnancy
did not differ from those collected at birth (p > 0.05) but
the levels in maternal blood were higher than samples
from the cord and breast milk (p < 0.001). Breast milk was
found to be higher than cord blood ΣPCBs (p = 0.008) all
tests after lipid-adjustment.
A similar pattern was identified for Group 2 and Group 3
PCBs. There were no differences between blood collected
during pregnancy and the samples taken at birth (n.s.).
There were higher concentrations in blood taken during
pregnancy and at birth over cord blood (p < 0.01) and
breast milk (p < 0.01). Breast milk was higher than cord
blood for Group 2 (p < 0.05) but not Group 3 PCBs.
PCB 153 concentrations were not different between
maternal blood during pregnancy and at birth although
they were all significantly higher than breast milk.
This increase in the concentrations of PCBs in the cord
blood samples was potentially a consequence of the rela-
tively low concentrations of lipid in the fetal circulation.
The levels of non-lipid adjusted levels of PCBs are shown
in Additional file: 2. The lipid concentrations of the tissue
compartments were as follows (mean +/- S dev.): mater-
nal blood during pregnancy – 0.71+/-0.13, at birth –
0.74+/-0.16, cord blood- 0.21+/-0.06 and breast milk –
2.83+/-1.33 g/100 ml plasma.
The pattern of PCBs among non-lipid adjusted groups is
shown in Additional file: 2. There was no difference in theEnvironmental Health: A Global Access Science Source 2005, 4:10 http://www.ehjournal.net/content/4/1/10
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maternal samples during pregnancy compared to the cord
blood samples. There were significantly higher levels of
both Groups in maternal blood during pregnancy and at
birth compared to cord blood, consistent with the Σ PCB
level pattern (p < 0.001)
The concentrations of pesticides are presented in Addi-
tional file: 2. There were no differences in lipid adjusted
HCB concentrations of maternal blood during pregnancy
and at birth when compared to cord blood (n.s.) There
were significantly lower concentrations of lipid adjusted
HCB in breast milk when compared to all other groups (p
< 0.001). The same pattern of result was observed for lipid
adjusted DDE samples.
Without lipid adjustment there was a significant differ-
ence in HCB in maternal blood during pregnancy and at
birth compared to cord blood (p < 0.001) (see Additional
file: 2). HCB during pregnancy and at birth were signifi-
cantly less than breast milk samples without lipid adjust-
ment (p < 0.001). The same pattern was observed for non-
lipid adjusted DDE samples.
PCB Correlations
The relationships of the Σ PCBs are closely correlated in all
of the tissues as indicated in Table 3. There are several
notable relationships with very high correlation coeffi-
cients. Non-lipid adjusted, normalized Σ PCBs during
pregnancy were found to highly correlate with levels at
birth (r = 0.770, p < 0.01) and in cord blood (r = 0.498, p
< 0.01) but not with breast milk (n.s.). Σ PCBs taken at
birth also correlated well with cord blood (p < 0.001) but
not with breast milk PCBs.
There were significant correlations between Group 2 and
3 PCBs (Additional file: 3). The most significant correla-
tions were between groups but within tissue compart-
ments. Group 2 PCBs of maternal blood during pregnancy
correlated most strongly with Group 3 PCBs of maternal
blood during pregnancy (r = 0.755, p < 0.01) but also
strongly correlated with Group 2 PCBs at birth (r = 0.628,
p < 0.01) and Group 3 PCBs at birth (r = 0.717, p < 0.001);
Group 3 PCBs of maternal blood during pregnancy also
correlated with Group 2 and 3 at birth and Group 2 and 3
cord blood (all p < 0.001). The Group 2 PCBs at birth cor-
related well with Group 2 and 3 cord blood cord (r =
0.603, p < 0.001 and r = 0.783, p < 0.001 respectively);
Group 3 PCBs at birth also correlated with Group 2 and 3
cord blood (all p < 0.001). There was no correlation
between breast milk and the other values.
To explore more rigorously the relationships of PCBs
between compartments PCB 153 and PCB 180 were eval-
uated among all subjects with completed collection of
maternal and fetal blood samples. These PCBs were
selected because of the relatively high rate of detection of
analytes. Cord blood PCB 153 was significantly correlated
with maternal blood during pregnancy (r = 0.691, p <
0.001) and maternal blood at birth (r = 0.905, p < 0.001).
Cord blood PCB 180 was also significantly correlated with
maternal blood during pregnancy (r = 0.511, p < 0.001)
and maternal blood at birth (r = 0.830, p < 0.001).
The correlations between the tissue compartments and
HCB and DDE are presented in Additional file: 4. Specifi-
cally, there were significant correlations for both HCB and
DDE between both the samples during pregnancy and at
birth when compared to cord blood (all p < 0.001).
Clinical Variables and Concentrations of PCBs and Pesticides
There were no differences in the concentrations of PCBs or
pesticides among women reporting one or two prior
Table 3: Correlation of ΣPCBs In Human Tissues
ΣPCB DP ΣPCB AB ΣPCB CB ΣPCB BM
ΣPCB DP r 1.000 0.759 0.357 0.504
p 0.000 0.001 0.001
n 97.000 91.000 40.000
ΣPCB AB r 1.000 0.600 0.325
p 0.000 0.075
n 87.000 31.000
ΣPCB CB r 1.000 -0.012
p 0.954
n 27.000Environmental Health: A Global Access Science Source 2005, 4:10 http://www.ehjournal.net/content/4/1/10
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spontaneous abortions compared to those individuals
who had had no spontaneous abortion. It should be
noted this was not the primary objective of the study and
the clinical outcomes are part of secondary analysis. There
were no significant differences in concentrations of PCBs
and pesticides among the subjects reporting medical con-
ditions with the exception that those individuals report-
ing infertility had significantly higher concentrations of
HCB. There were no differences in these concentrations
among women reporting exposure to herbicides, pesti-
cides, fungicides or insecticides compared to those report-
ing no such exposure in the previous year. Similarly, there
was no significant association of a particular diet (weight
loss, diabetic, salt free, low fat) with the measurement of
PCB and pesticides in this cohort of subjects. Although
there was a dose related increase in the mean concentra-
tions of Σ PCBs in maternal blood during pregnancy in
relation to fish consumption, the relationship was not
significant.
Discussion
The results of this study are reassuring and support the
observations that indicate levels of PCBs are relatively low
in western Canada compared to other studies in previous
years among pregnant women in different countries or
regions of Canada. Specifically, using PCB 153 as a marker
as recommended [23], it would appear the women in Cal-
gary are at the lower range of values among studies that
evaluated neurocognitive outcomes of children. The meta
analysis of ten studies indicated a range of the 25th to the
75th percentiles of PCB 153 to range from approximately
20 to 800 ng/g lipid [18]. In this study, the arithmetic
mean concentrations of PCB 153 were 21.16, 25.71 and
18.22 ng/g lipid in the maternal blood during pregnancy,
at birth and cord blood respectively, indicating a relatively
low exposure level in relation to the previous reports.
There is evidence that the maternal serum during the sec-
ond trimester of pregnancy can be considered a biomarker
for the exposure of the fetus in utero as determined by cord
blood levels and the significant correlations among these
tissue compartments. These observations have been made
previously at higher PCB concentrations [3]
The concentrations of this study are consistent with other
reports of the concentrations of PCB 153, HCB and DDE
in the cord samples. Specifically, there is close agreement
with the findings in southern Quebec, Canada and New
Bedford, USA for all three chemicals measured on a wet
weight basis [24]. Additionally the combination of PCB
138, 153 and 180 in the New Bedford study was approxi-
mately twice the concentrations of the same PCBs in the
current study (mean, median and standard deviation:
0.84, 0.6, 1.14 ng/ml respectively), and agreed more
closely with the Σ PCBs which contained PCBs 74, 118,
138, 153, 187, 183, 156, 180, 170. These differences may
reflect a greater exposure in New Bedford than in southern
Alberta. The differences in cord concentrations from other
reports of higher levels may be a reflection of the declin-
ing concentrations in recent years since the chemicals
were banned [25-28]. Decreases in tissue concentrations
have been reported in Northern Canada between 1994
and 2001 [29]. The lower concentrations may also reflect
the findings of a population study of healthy women
attending a genetics counselling service that was unse-
lected for dietary intake of foods containing PCBs [30].
Absence of these chemicals in the amniotic fluid at the
level of quantification was observed but not unantici-
pated because of the low lipid concentration, an assess-
ment of the amniocytes may have isolated analytes [31,
32]. In this study the cells were not available owing the
need for karyotyping.
There were a number of important findings from this
cohort that again indicate the relatively low concentra-
tions did not exercise a measurable biological effect of the
prior health of the women. For example, there were no
differences in the concentrations of PCBs or pesticides
among women reporting prior spontaneous abortion. The
sample size may be too small to detect a significant
increase. The higher concentrations of HCB during preg-
nancy among those reporting infertility may simply reflect
the lack of prior pregnancy-related loss of body burden
and is not interpreted as a causal function of infertility.
There were no significant differences in the concentrations
of PCBs and pesticides among the subjects reporting cur-
rent or previous serious medical conditions or exposure to
pesticides, fungicides, herbicides or other common chem-
icals such as dry cleaning fluid in the previous year. Simi-
larly, there was no significant association of diet with the
measurement of Σ PCB and pesticides in this cohort of
subjects. Although there was an increase in the mean con-
centrations of Σ PCBs in relation to daily fish consump-
tion, the relationship of diet was not significant.
Conclusion
In summary, it would appear that pregnant subjects from
Calgary Alberta are exposed to PCBs and pesticides as are
most individuals but the extent of exposure appears to be
low in relation to other published studies from other areas
of Canada or other countries. There is no evidence of
exposure to pesticides or PCBs in the amniotic fluid under
the current measurement limitations of quantification.
Measurement of maternal blood during the second tri-
mester of pregnancy reliably estimates the maternal blood
levels at birth as well as fetal exposure to PCBs and organ-
ochlorines as measured by cord blood at these relatively
low levels. The evaluation of subjects who had complete
blood sampling indicated specifically that the cord bloodEnvironmental Health: A Global Access Science Source 2005, 4:10 http://www.ehjournal.net/content/4/1/10
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PCB 153 and PCB 180 are reliably predicted by a measure
of maternal blood during the second trimester of
pregnancy.
List of Abbreviations
DP: maternal blood taken during the first trimester of
pregnancy
AB: Maternal blood taken at the time of birth
C Blood taken from the cord at birth
BM: Breast milk
DDE: Dichlorodiphenyldichloroethylene
HCB: Hexachlorobenzene
DDT: Dichlorodiphenyltrichloroethane
PCBs: Polychlorinated biphenyls
PCB 70 2,3',4',5-Tetrachlorobiphenyl
PCB 74 2,4,4',5-Tetrachlorobiphenyl
PCB 77 3,3',4,4'-Tetrachlorobiphenyl
PCB 87 2,2'3,4,5'-Pentachlorobiphenyl
PCB 99 2,2',4,4'5-Pentachlorobiphenyl
PCB 101 2,2'4,5,5'-Pentachlorobiphenyl
PCB 105 2,3,3',4,4'-Pentachlorobiphenyl
PCB 118 2,3',4,4',5-Pentachlorobiphenyl
PCB 128 2,2',3,3',4,4'-Hexachlorobiphenyl
PCB 138 2,2',3,4,4',5'-Hexachlorobiphenyl
PCB 151 2,2',3,5,5'6-Hexachlorobiphenyl
PCB 153 2,2',4,4',5,5'-Hexachlorobiphenyl
PCB 156 2,3,3'4,4',5-Hexachlorobiphenyl
PCB 169 3,3'4,4',5,5'-Hexachlorobiphenyl
PCB 170 2,2',3,3',4,4',5-Heptachlorobiphenyl
PCB 180 2,2',3,4,4',5,5'-Heptachlorbiphenyl
PCB 183 2,2'3,4,4'5',6-Heptachlorbiphenyl
PCB 187 2,2',3,4',5,5',6-Heptachlorbiphenyl
PCB 191 2,3,3',4,4',5',6-Heptachlorbiphenyl
PCB 194 2,2',3,3',4,4'5,5'-Octachlorbiphenyl
PCB 205 2,3,3',4,4',5,5',6-Octachlorobiphenyl
PCB 206 2,2',3,3',4,4',5,5',6-Nonachlorbiphenyl
PCB 208 2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl
PCB 209 Decachlorobiphenyl
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